The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Advances in the development of influenza virus vaccines
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Garten, R. J., Davis, C. T., Russell, C. A., Shu, B., Lindstrom, S., Balish, A., Sessions, W. M., Xu, X., Skepner, E., Deyde, V., et al. (2009) · Science · doi:10.1126/science.1176225 · Cited by 2,499
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
Gao, R., Cao, B., Hu, Y., Feng, Z., Wang, D., Hu, W., Chen, J., Jie, Z., Qiu, H., Xu, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304459 · Cited by 2,310
Updating the accounts: global mortality of the 1918–1920 "Spanish" influenza pandemic.
Johnson, N. P. A. S., & Mueller, J. (2002) · Bulletin of the History of Medicine · doi:10.1353/bhm.2002.0022 · Cited by 1,980
Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus
Claas, E. C., Osterhaus, A. D., van Beek, R., De Jong, J. C., Rimmelzwaan, G. F., Senne, D. A., Krauss, S., Shortridge, K. F., & Webster, R. G. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11212-0 · Cited by 1,429
Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses
Hatta, M., Gao, P., Halfmann, P., & Kawaoka, Y. (2001) · Science · doi:10.1126/science.1062882 · Cited by 1,338
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J., & Wilson, I. A. (2009) · Science · doi:10.1126/science.1171491 · Cited by 1,326
Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A., Vanzetta, F., et al. (2011) · Science · doi:10.1126/science.1205669 · Cited by 1,203
Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L.-M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,130
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
Wrammert, J., Smith, K., Miller, J., Langley, W. A., Kokko, K., Larsen, C., Zheng, N.-Y., Mays, I., Garman, L., Helms, C., et al. (2008) · Nature · doi:10.1038/nature06890 · Cited by 1,025
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
DiazGranados, C. A., Dunning, A. J., Kimmel, M., Kirby, D., Treanor, J., Collins, A., Pollak, R., Christoff, J., Earl, J., Landolfi, V., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315727 · Cited by 876
Highly Conserved Protective Epitopes on Influenza B Viruses
Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 866
Cellular immune correlates of protection against symptomatic pandemic influenza
Sridhar, S., Begom, S., Bermingham, A., Hoschler, K., Adamson, W., Carman, W., Bean, T., Barclay, W., Deeks, J. J., & Lalvani, A. (2013) · Nature Medicine · doi:10.1038/nm.3350 · Cited by 862
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M., Brandenburg, B., et al. (2011) · Science · doi:10.1126/science.1204839 · Cited by 822
Wrammert, J., Koutsonanos, D., Li, G.-M., Edupuganti, S., Sui, J., Morrissey, M., McCausland, M., Skountzou, I., Hornig, M., Lipkin, W. I., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101352 · Cited by 777
Rescue of Influenza A Virus from Recombinant DNA
Fodor, E., Devenish, L., Engelhardt, O. G., Palese, P., Brownlee, G. G., & García-Sastre, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9679-9682.1999 · Cited by 775
Self-citationA universal influenza A vaccine based on the extracellular domain of the M2 protein
Neirynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Jou, W. M., & Fiers, W. (1999) · Nature Medicine · doi:10.1038/13484 · Cited by 752
DiLillo, D. J., Tan, G. S., Palese, P., & Ravetch, J. V. (2014) · Nature Medicine · doi:10.1038/nm.3443 · Cited by 749
Self-citationThrosby, M., van den Brink, E., Jongeneelen, M., Poon, L. L. M., Alard, P., Cornelissen, L., Bakker, A., Cox, F., van Deventer, E., Guan, Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003942 · Cited by 737
The Structure and Receptor Binding Properties of the 1918 Influenza Hemagglutinin
Gamblin, S. J., Haire, L. F., Russell, R. J., Stevens, D. J., Xiao, B., Ha, Y., Vasisht, N., Steinhauer, D. A., Daniels, R. S., Elliot, A., et al. (2004) · Science · doi:10.1126/science.1093155 · Cited by 712
Chen, H., Yuan, H., Gao, R., Zhang, J., Wang, D., Xiong, Y., Fan, G., Yang, F., Li, X., Zhou, J., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60111-2 · Cited by 647
Influenza: old and new threats
Palese, P. (2004) · Nature Medicine · doi:10.1038/nm1141 · Cited by 603
Self-citationInfluenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
Steel, J., Lowen, A. C., Wang, T. T., Yondola, M., Gao, Q., Haye, K., García-Sastre, A., & Palese, P. (2010) · mBio · doi:10.1128/mbio.00018-10 · Cited by 533
Self-citationThe annual production cycle for influenza vaccine
Gerdil, C. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00071-9 · Cited by 529
Okuno, Y., Isegawa, Y., Sasao, F., & Ueda, S. (1993) · Journal of Virology · doi:10.1128/jvi.67.5.2552-2558.1993 · Cited by 489
Cross-neutralization of influenza A viruses mediated by a single antibody loop
Ekiert, D. C., Kashyap, A. K., Steel, J., Rubrum, A., Bhabha, G., Khayat, R., Lee, J. H., Dillon, M. A., O’Neil, R. E., Faynboym, A. M., et al. (2012) · Nature · doi:10.1038/nature11414 · Cited by 481
Self-citationWhittle, J. R. R., Zhang, R., Khurana, S., King, L. R., Manischewitz, J., Golding, H., Dormitzer, P. R., Haynes, B. F., Walter, E. B., Moody, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111497108 · Cited by 439
Corti, D., Suguitan, A. L., Pinna, D., Silacci, C., Fernandez-Rodriguez, B. M., Vanzetta, F., Santos, C., Luke, C. J., Torres-Velez, F. J., Temperton, N. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41902 · Cited by 437
Role of receptor binding specificity in influenza A virus transmission and pathogenesis
de Graaf, M., & Fouchier, R. A. M. (2014) · The EMBO Journal · doi:10.1002/embj.201387442 · Cited by 435
Krammer, F., Pica, N., Hai, R., Margine, I., & Palese, P. (2013) · Journal of Virology · doi:10.1128/jvi.00641-13 · Cited by 423
Self-citationTricco, A. C., Chit, A., Soobiah, C., Hallett, D., Meier, G., Chen, M. H., Tashkandi, M., Bauch, C. T., & Loeb, M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-153 · Cited by 390
Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Berthoud, T. K., Hamill, M., Lillie, P. J., Hwenda, L., Collins, K. A., Ewer, K. J., Milicic, A., Poyntz, H. C., Lambe, T., Fletcher, H. A., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq015 · Cited by 384
Huleatt, J. W., Nakaar, V., Desai, P., Huang, Y., Hewitt, D., Jacobs, A., Tang, J., McDonald, W., Song, L., Evans, R. K., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.10.062 · Cited by 382
D’Aoust, M., Couture, M. M. ‐., Charland, N., Trépanier, S., Landry, N., Ors, F., & Vézina, L. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2009.00496.x · Cited by 371
Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
Wei, C.-J., Boyington, J. C., McTamney, P. M., Kong, W.-P., Pearce, M. B., Xu, L., Andersen, H., Rao, S., Tumpey, T. M., Yang, Z.-Y., et al. (2010) · Science · doi:10.1126/science.1192517 · Cited by 337
El Bakkouri, K., Descamps, F., De Filette, M., Smet, A., Festjens, E., Birkett, A., Van Rooijen, N., Verbeek, S., Fiers, W., & Saelens, X. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0902147 · Cited by 335
Influenza virus hemagglutinin stalk-based antibodies and vaccines
Krammer, F., & Palese, P. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.07.007 · Cited by 326
Self-citationGlycans on influenza hemagglutinin affect receptor binding and immune response
Wang, C.-C., Chen, J.-R., Tseng, Y.-C., Hsu, C.-H., Hung, Y.-F., Chen, S.-W., Chen, C.-M., Khoo, K.-H., Cheng, T.-J., Cheng, Y.-S. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909696106 · Cited by 316
The history of MF59 ® adjuvant: a phoenix that arose from the ashes
O’Hagan, D. T., Ott, G. S., Nest, G. V., Rappuoli, R., & Giudice, G. D. (2013) · Expert Review of Vaccines · doi:10.1586/erv.12.140 · Cited by 313
Wang, T. T., Tan, G. S., Hai, R., Pica, N., Ngai, L., Ekiert, D. C., Wilson, I. A., García-Sastre, A., Moran, T. M., & Palese, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013387107 · Cited by 302
Self-citationLandry, N., Ward, B. J., Trépanier, S., Montomoli, E., Dargis, M., Lapini, G., & Vézina, L.-P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015559 · Cited by 281
D’Aoust, M., Lavoie, P., Couture, M. M. ‐., Trépanier, S., Guay, J., Dargis, M., Mongrand, S., Landry, N., Ward, B. J., & Vézina, L. (2008) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2008.00384.x · Cited by 279
Hai, R., Krammer, F., Tan, G. S., Pica, N., Eggink, D., Maamary, J., Margine, I., Albrecht, R. A., & Palese, P. (2012) · Journal of Virology · doi:10.1128/jvi.00137-12 · Cited by 278
Self-citationWang, T. T., Tan, G. S., Hai, R., Pica, N., Petersen, E., Moran, T. M., & Palese, P. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000796 · Cited by 278
Self-citationAdaptation and Growth Characteristics of Influenza Virus at 25° C
MAASSAB, H. F. (1967) · Nature · doi:10.1038/213612a0 · Cited by 274
Tate, M., Job, E., Deng, Y.-M., Gunalan, V., Maurer-Stroh, S., & Reading, P. (2014) · Viruses · doi:10.3390/v6031294 · Cited by 263
Structural Characterization of the 1918 Influenza Virus H1N1 Neuraminidase
Xu, X., Zhu, X., Dwek, R. A., Stevens, J., & Wilson, I. A. (2008) · Journal of Virology · doi:10.1128/jvi.00959-08 · Cited by 260
Steel, J., Lowen, A. C., Pena, L., Angel, M., Solórzano, A., Albrecht, R., Perez, D. R., García-Sastre, A., & Palese, P. (2009) · Journal of Virology · doi:10.1128/jvi.01920-08 · Cited by 258
Self-citationInduction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine
Couch, R. B., Kasel, J. A., Gerin, J. L., Schulman, J. L., & Kilbourne, E. D. (1974) · Journal of Infectious Diseases · doi:10.1093/infdis/129.4.411 · Cited by 257
Kashyap, A. K., Steel, J., Oner, A. F., Dillon, M. A., Swale, R. E., Wall, K. M., Perry, K. J., Faynboym, A., Ilhan, M., Horowitz, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801367105 · Cited by 252
Self-citationPica, N., Hai, R., Krammer, F., Wang, T. T., Maamary, J., Eggink, D., Tan, G. S., Krause, J. C., Moran, T., Stein, C. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200039109 · Cited by 250
Self-citationPreliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
Lillie, P. J., Berthoud, T. K., Powell, T. J., Lambe, T., Mullarkey, C., Spencer, A. J., Hamill, M., Peng, Y., Blais, M.-E., Duncan, C. J. A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis327 · Cited by 248
Whittle, J. R. R., Wheatley, A. K., Wu, L., Lingwood, D., Kanekiyo, M., Ma, S. S., Narpala, S. R., Yassine, H. M., Frank, G. M., Yewdell, J. W., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03422-13 · Cited by 247
Ellebedy, A. H., Krammer, F., Li, G.-M., Miller, M. S., Chiu, C., Wrammert, J., Chang, C. Y., Davis, C. W., McCausland, M., Elbein, R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414070111 · Cited by 234
Self-citationde Jong, J. C., Beyer, W. E. P., Palache, A. M., Rimmelzwaan, G. F., & Osterhaus, A. D. M. E. (2000) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(200005)61:1<94::aid-jmv15>3.0.co;2-c · Cited by 230
Universal influenza A vaccine: Optimization of M2-based constructs
De Filette, M., Min Jou, W., Birkett, A., Lyons, K., Schultz, B., Tonkyro, A., Resch, S., & Fiers, W. (2005) · Virology · doi:10.1016/j.virol.2005.04.004 · Cited by 223
Recombinant protein vaccines produced in insect cells
Cox, M. M. J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.016 · Cited by 223
Development of a mammalian cell (Vero) derived candidate influenza virus vaccine
KISTNER, O. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00301-0 · Cited by 221
Human infection with avian influenza A H6N1 virus: an epidemiological analysis
Wei, S.-H., Yang, J.-R., Wu, H.-S., Chang, M.-C., Lin, J.-S., Lin, C.-Y., Liu, Y.-L., Lo, Y.-C., Yang, C.-H., Chuang, J.-H., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70221-2 · Cited by 218
Lu, Y., Welsh, J. P., & Swartz, J. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308701110 · Cited by 216
Jegaskanda, S., Job, E. R., Kramski, M., Laurie, K., Isitman, G., de Rose, R., Winnall, W. R., Stratov, I., Brooks, A. G., Reading, P. C., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201574 · Cited by 215
Bommakanti, G., Citron, M. P., Hepler, R. W., Callahan, C., Heidecker, G. J., Najar, T. A., Lu, X., Joyce, J. G., Shiver, J. W., Casimiro, D. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007465107 · Cited by 214
Lee, P. S., Ohshima, N., Stanfield, R. L., Yu, W., Iba, Y., Okuno, Y., Kurosawa, Y., & Wilson, I. A. (2014) · Nature Communications · doi:10.1038/ncomms4614 · Cited by 213
GlyProt: in silico glycosylation of proteins
Bohne-Lang, A., & von der Lieth, C.-W. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki385 · Cited by 207
Krause, J. C., Tsibane, T., Tumpey, T. M., Huffman, C. J., Basler, C. F., & Crowe, J. E. (2011) · Journal of Virology · doi:10.1128/jvi.00700-11 · Cited by 204
Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial
Steinhoff, M. C., Omer, S. B., Roy, E., Arifeen, S. E., Raqib, R., Dodd, C., Breiman, R. F., & Zaman, K. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.110754 · Cited by 204
Emergence of Fatal Avian Influenza in New England Harbor Seals
Anthony, S. J., St. Leger, J. A., Pugliares, K., Ip, H. S., Chan, J. M., Carpenter, Z. W., Navarrete-Macias, I., Sanchez-Leon, M., Saliki, J. T., Pedersen, J., et al. (2012) · mBio · doi:10.1128/mbio.00166-12 · Cited by 202
Giles, B. M., & Ross, T. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.100 · Cited by 199
Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
Margine, I., Krammer, F., Hai, R., Heaton, N. S., Tan, G. S., Andrews, S. A., Runstadler, J. A., Wilson, P. C., Albrecht, R. A., García-Sastre, A., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01715-13 · Cited by 197
Self-citationKissling, E., Valenciano, M., Larrauri, A., Oroszi, B., Cohen, J. M., Nunes, B., Pitigoi, D., Rizzo, C., Rebolledo, J., Paradowska-Stankiewicz, I., et al. (2013) · Eurosurveillance · doi:10.2807/ese.18.05.20390-en · Cited by 195
Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments
Schotsaert, M., De Filette, M., Fiers, W., & Saelens, X. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.6 · Cited by 195
Mallajosyula, V. V. A., Citron, M., Ferrara, F., Lu, X., Callahan, C., Heidecker, G. J., Sarma, S. P., Flynn, J. A., Temperton, N. J., Liang, X., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402766111 · Cited by 191
Miller, M. S., Gardner, T. J., Krammer, F., Aguado, L. C., Tortorella, D., Basler, C. F., & Palese, P. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006637 · Cited by 190
Self-citationInfluenza Vaccine Effectiveness in the Community and the Household
Ohmit, S. E., Petrie, J. G., Malosh, R. E., Cowling, B. J., Thompson, M. G., Shay, D. K., & Monto, A. S. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit060 · Cited by 188
Eggink, D., Goff, P. H., & Palese, P. (2014) · Journal of Virology · doi:10.1128/jvi.02608-13 · Cited by 186
Self-citationImmune history shapes specificity of pandemic H1N1 influenza antibody responses
Li, Y., Myers, J. L., Bostick, D. L., Sullivan, C. B., Madara, J., Linderman, S. L., Liu, Q., Carter, D. M., Wrammert, J., Esposito, S., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130212 · Cited by 184
Jegaskanda, S., Weinfurter, J. T., Friedrich, T. C., & Kent, S. J. (2013) · Journal of Virology · doi:10.1128/jvi.03030-12 · Cited by 183
Evolutionary Dynamics and Emergence of Panzootic H5N1 Influenza Viruses
Vijaykrishna, D., Bahl, J., Riley, S., Duan, L., Zhang, J. X., Chen, H., Peiris, J. S. M., Smith, G. J. D., & Guan, Y. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000161 · Cited by 182
A common solution to group 2 influenza virus neutralization
Friesen, R. H. E., Lee, P. S., Stoop, E. J. M., Hoffman, R. M. B., Ekiert, D. C., Bhabha, G., Yu, W., Juraszek, J., Koudstaal, W., Jongeneelen, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319058110 · Cited by 182
Nakamura, G., Chai, N., Park, S., Chiang, N., Lin, Z., Chiu, H., Fong, R., Yan, D., Kim, J., Zhang, J., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.06.004 · Cited by 178
Cochrane re-arranged: Support for policies to vaccinate elderly people against influenza
Beyer, W. E. P., McElhaney, J., Smith, D. J., Monto, A. S., Nguyen-Van-Tam, J. S., & Osterhaus, A. D. M. E. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.09.063 · Cited by 175
Krammer, F., Margine, I., Tan, G. S., Pica, N., Krause, J. C., & Palese, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043603 · Cited by 173
Self-citationA Recombinant Viruslike Particle Influenza A (H7N9) Vaccine
Fries, L. F., Smith, G. E., & Glenn, G. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1313186 · Cited by 167
Wohlbold, T., & Krammer, F. (2014) · Viruses · doi:10.3390/v6062465 · Cited by 166
Self-citationMoody, M. A., Zhang, R., Walter, E. B., Woods, C. W., Ginsburg, G. S., McClain, M. T., Denny, T. N., Chen, X., Munshaw, S., Marshall, D. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025797 · Cited by 165
Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization
Brandenburg, B., Koudstaal, W., Goudsmit, J., Klaren, V., Tang, C., Bujny, M. V., Korse, H. J. W. M., Kwaks, T., Otterstrom, J. J., Juraszek, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080034 · Cited by 164
Margine, I., Hai, R., Albrecht, R. A., Obermoser, G., Harrod, A. C., Banchereau, J., Palucka, K., García-Sastre, A., Palese, P., Treanor, J. J., et al. (2013) · Journal of Virology · doi:10.1128/jvi.03509-12 · Cited by 163
Self-citationA Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum Efficacy In Vivo
Tan, G. S., Krammer, F., Eggink, D., Kongchanagul, A., Moran, T. M., & Palese, P. (2012) · Journal of Virology · doi:10.1128/jvi.00469-12 · Cited by 161
Self-citationInduction of Broadly Reactive Anti-Hemagglutinin Stalk Antibodies by an H5N1 Vaccine in Humans
Nachbagauer, R., Wohlbold, T. J., Hirsh, A., Hai, R., Sjursen, H., Palese, P., Cox, R. J., & Krammer, F. (2014) · Journal of Virology · doi:10.1128/jvi.02133-14 · Cited by 152
Self-citationSafety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine
Atsmon, J., Kate-Ilovitz, E., Shaikevich, D., Singer, Y., Volokhov, I., Haim, K. Y., & Ben-Yedidia, T. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9632-5 · Cited by 148
Wan, H., Gao, J., Xu, K., Chen, H., Couzens, L. K., Rivers, K., Easterbrook, J. D., Yang, Y., Zhong, L., Rajabi, M., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01203-13 · Cited by 146
Graves, P. N., Schulman, J. L., Young, J. F., & Palese, P. (1983) · Virology · doi:10.1016/0042-6822(83)90465-8 · Cited by 142
Self-citationSeroevidence for H5N1 Influenza Infections in Humans: Meta-Analysis
Wang, T. T., Parides, M. K., & Palese, P. (2012) · Science · doi:10.1126/science.1218888 · Cited by 142
Self-citationA phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
Cox, R. J., Madhun, A. S., Hauge, S., Sjursen, H., Major, D., Kühne, M., Höschler, K., Saville, M. K., Vogel, F. R., Barclay, W., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.116 · Cited by 140
Johansson, B. E., Moran, T. M., & Kilbourne, E. D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6869 · Cited by 138
Mulligan, M. J., Bernstein, D. I., Winokur, P. L., Rupp, R. E., Anderson, E. J., Rouphael, N., Dickey, M., Stapleton, J. T., Edupuganti, S., Spearman, P. W., et al. (2014) · JAMA · doi:10.1001/jama.2014.12854 · Cited by 136
Altenburg, A. F., Kreijtz, J. H. C. M., de Vries, R. D., Song, F., Fux, R., Rimmelzwaan, G. F., Sutter, G., & Volz, A. (2014) · Viruses · doi:10.3390/v6072735 · Cited by 135
López-Macías, C. I. R., Ferat-Osorio, E. A., Tenorio-Calvo, A. V., Isibasi, A., Talavera, J. O., Arteaga-Ruiz, O., Arriaga‐Pizano, L., Hickman, S. P., Allende, M. C., Lenhard, K., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.099 · Cited by 135
Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children
Jain, V. K., Rivera, L., Zaman, K., Espos, R. A., Sirivichayakul, C., Quiambao, B. P., Rivera-Medina, D. M., Kerdpanich, P., Ceyhan, M., Dinleyici, E. Ç., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215817 · Cited by 134
Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets
Krammer, F., Hai, R., Yondola, M. A., Tan, G. S., Leyva-Grado, V. H., Ryder, A. B., Miller, M. S., Rose, J. K., Palese, P., García‐Sastre, A., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03004-13 · Cited by 134
Self-citationTaylor, D. N., Treanor, J. J., Sheldon, E. A., Johnson, C., Umlauf, S., Song, L., Kavita, U., Liu, G., Tussey, L., Ozer, K., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.086 · Cited by 132
Ramos, E. L., Mitcham, J. L., Koller, T. D., Bonavia, A., Usner, D. W., Balaratnam, G., Fredlund, P. N., & Swiderek, K. M. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu539 · Cited by 132
Medina, R., Stertz, S., Manicassamy, B., Zimmermann, P., Sun, X., Albrecht, R. A., Uusi-Kerttula, H. K., Zagordi, O., Belshe, R. B., Frey, S. E., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005996 · Cited by 128
Antrobus, R., Lillie, P. J., Berthoud, T. K., Spencer, A. J., McLaren, J. E., Ladell, K., Lambe, T., Milicic, A., Price, D. A., Hill, A. V. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048322 · Cited by 128
An Influenza A Vaccine Based on Tetrameric Ectodomain of Matrix Protein 2
Filette, M. D., Martens, W., Roose, K., Deroo, T., Vervalle, F., Bentahir, M., Vandekerckhove, J. S., Fiers, W. C., & Saelens, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800650200 · Cited by 127
DiazGranados, C. A., Dunning, A. J., Jordanov, E., Landolfi, V. A., Denis, M., & Talbot, H. K. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.12.013 · Cited by 123
Ledgerwood, J. E., Zephir, K., Hu, Z., Wei, C.-J., Chang, L., Enama, M. E., Hendel, C. S., Sitar, S., Bailer, R. T., Koup, R. A., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit180 · Cited by 123
Tan, G. S., Lee, P. S., Hoffman, R. M. B., Mazel‐Sanchez, B., Krammer, F., Leon, P. E., Ward, A. B., Wilson, I. A., & Palese, P. (2014) · Journal of Virology · doi:10.1128/jvi.02289-14 · Cited by 121
Self-citationHillaire, M. L. B., Trierum, S. E. V.-V., Kreijtz, J. H. C. M., Bodewes, R., Geelhoed-Mieras, M. M., Nieuwkoop, N. J., Fouchier, R. A. M., Kuiken, T., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2011) · Journal of General Virology · doi:10.1099/vir.0.033076-0 · Cited by 121
Influenza-Specific Antibody-Dependent Cellular Cytotoxicity: Toward a Universal Influenza Vaccine
Jegaskanda, S., Reading, P. C., & Kent, S. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400432 · Cited by 120
Giles, B. M., Crevar, C. J., Carter, D. M., Bissel, S. J., Schultz‐Cherry, S., Wiley, C. A., & Ross, T. M. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis232 · Cited by 119
Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults
Karron, R. A., Talaat, K. R., Luke, C. J., Callahan, K. A., Thumar, B., DiLorenzo, S. C., McAuliffe, J. M., Schappell, E., Suguitan, A. L., Mills, K., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.099 · Cited by 118
A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine
Couch, R. B., Patel, S. M., Wade-Bowers, C. L., & Niño, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049704 · Cited by 116
Why Do Influenza Virus Subtypes Die Out? A Hypothesis
Palese, P., & Wang, T. T. (2011) · mBio · doi:10.1128/mbio.00150-11 · Cited by 115
Self-citationOhshima, N., Iba, Y., Kubota‐Koketsu, R., Asano, Y., Okuno, Y., & Kurosawa, Y. (2011) · Journal of Virology · doi:10.1128/jvi.05397-11 · Cited by 115
Thomson, C. A., Wang, Y., Jackson, L. M., Olson, M., Wang, W., Liavonchanka, A., Keleta, L., da Silva, V. G. L., Diederich, S., Jones, R. B., et al. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00087 · Cited by 114
H3 Stalk-Based Chimeric Hemagglutinin Influenza Virus Constructs Protect Mice from H7N9 Challenge
Krammer, F., Margine, I., Hai, R., Flood, A., Hirsh, A., Tsvetnitsky, V., Chen, D., & Palese, P. (2013) · Journal of Virology · doi:10.1128/jvi.03183-13 · Cited by 113
Self-citationEffect of Influenza Vaccination in the First Trimester of Pregnancy
Sheffield, J. S., Greer, L. G., Rogers, V. L., Roberts, S. W., Lytle, H., McIntire, D. D., & Wendel, G. D. (2012) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e318263a278 · Cited by 111
Universal anti-neuraminidase antibody inhibiting all influenza A subtypes
Doyle, T. M., Hashem, A. M., Li, C., Domselaar, G. V., Larocque, L., Wang, J., Smith, D. G. S., Cyr, T. D., Farnsworth, A., He, R., et al. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.09.018 · Cited by 110
van de Sandt, C. E., Kreijtz, J. H. C. M., de Mutsert, G., Geelhoed-Mieras, M. M., Hillaire, M. L. B., Trierum, S. E. V.-V., Osterhaus, A. D. M. E., Fouchier, R. A. M., & Rimmelzwaan, G. F. (2013) · Journal of Virology · doi:10.1128/jvi.02843-13 · Cited by 109
Harris, A. K., Meyerson, J. R., Matsuoka, Y., Kuybeda, O., Moran, A., Bliss, D., Das, S. R., Yewdell, J. W., Sapiro, G., Subbarao, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214913110 · Cited by 107
Easterbrook, J. D., Schwartzman, L. M., Gao, J., Kash, J. C., Morens, D. M., Couzens, L. K., Wan, H., Eichelberger, M. C., & Taubenberger, J. K. (2012) · Virology · doi:10.1016/j.virol.2012.06.003 · Cited by 106
Westgeest, K. B., de Graaf, M., Fourment, M., Bestebroer, T. M., van Beek, R., Spronken, M. I. J., de Jong, J. C., Rimmelzwaan, G. F., Russell, C. A., Osterhaus, A. D. M. E., et al. (2012) · Journal of General Virology · doi:10.1099/vir.0.043059-0 · Cited by 106
Antrobus, R., Berthoud, T. K., Mullarkey, C. E., Höschler, K., Coughlan, L., Zambon, M. C. F. A., Hill, A. V. S., & Gilbert, S. C. (2013) · Molecular Therapy · doi:10.1038/mt.2013.162 · Cited by 104
Terajima, M., Cruz, J., Co, M. D. T., Lee, J.-H., Kaur, K., Wilson, P. C., & Ennis, F. A. (2011) · Journal of Virology · doi:10.1128/jvi.05193-11 · Cited by 104
Yang, C., Skiena, S., Futcher, B., Mueller, S., & Wimmer, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307473110 · Cited by 103
Baz, M., Luke, C. J., Cheng, X., Jin, H., & Subbarao, K. (2013) · Virus Research · doi:10.1016/j.virusres.2013.05.006 · Cited by 101
Talaat, K. R., Luke, C. J., Khurana, S., Manischewitz, J. F., King, L. R., McMahon, B. A., Karron, R. A., Lewis, K. D. C., Qin, J., Follmann, D. A., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu123 · Cited by 100
Krammer, F., Pica, N., Hai, R., Tan, G. S., & Palese, P. (2012) · Journal of Virology · doi:10.1128/jvi.01336-12 · Cited by 97
Self-citationTalaat, K. R., Karron, R. A., Callahan, K. A., Luke, C. J., DiLorenzo, S. C., Chen, G. L., Lamirande, E. W., Jin, H., Coelingh, K. L., Murphy, B. R., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.082 · Cited by 90
Atsmon, J., Caraco, Y., Ziv-Sefer, S., Shaikevich, D., Abramov, E., Volokhov, I., Bruzil, S., Haima, K. Y., Gottlieb, T. M., & Ben-Yedidia, T. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.08.031 · Cited by 88
Pseudotyped Influenza A Virus as a Vaccine for the Induction of Heterotypic Immunity
Powell, T. J., Silk, J. D., Sharps, J. L., Fodor, E., & Townsend, A. (2012) · Journal of Virology · doi:10.1128/jvi.01820-12 · Cited by 85
Live Attenuated Influenza Vaccine
Jin, H., & Subbarao, K. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_410 · Cited by 84
Bommakanti, G., Lu, X., Citron, M. P., Najar, T. A., Heidecker, G. J., ter Meulen, J., Varadarajan, R., & Liang, X. (2012) · Journal of Virology · doi:10.1128/jvi.01429-12 · Cited by 82
Giles, B. M., Bissel, S. J., DeAlmeida, D. R., Wiley, C. A., & Ross, T. M. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05533-11 · Cited by 81
Hensley, S. E. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.07.007 · Cited by 79
Tinoco, J. C., Pavía-Ruz, N., Cruz-Valdéz, A., Doniz, C. A., Chandrasekaran, V., Dewé, W., Liu, A., Innis, B. L., & Jain, V. K. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.022 · Cited by 78
1976 and 2009 H1N1 Influenza Virus Vaccines Boost Anti-Hemagglutinin Stalk Antibodies in Humans
Miller, M. S., Tsibane, T., Krammer, F., Hai, R., Rahmat, S., Basler, C. F., & Palese, P. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis652 · Cited by 77
Self-citationLambe, T., Carey, J. B., Li, Y., Spencer, A. J., van Laarhoven, A., Mullarkey, C. E., Vrdoljak, A., Moore, A., & Gilbert, S. C. (2013) · Scientific Reports · doi:10.1038/srep01443 · Cited by 76
Inactivated and Adjuvanted Influenza Vaccines
Giudice, G. D., & Rappuoli, R. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_406 · Cited by 75
Kreijtz, J. H. C. M., Suezer, Y., de Mutsert, G., van den Brand, J. M. A., van Amerongen, G., Schnierle, B. S., Kuiken, T., Fouchier, R. A. M., Löwer, J., Osterhaus, A. D. M. E., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/595984 · Cited by 75
Chen, J.-R., Yu, Y., Tseng, Y.-C., Chiang, W.-L., Chiang, M.-F., Ko, Y., Chiu, Y.-K., Ma, H., Wu, C., Jan, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323954111 · Cited by 75
Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
Krause, J. C., Tsibane, T., Tumpey, T. M., Huffman, C. J., Albrecht, R. A., Blum, D. L., Ramos, I., Fernández-Sesma, A., Edwards, K. M., García‐Sastre, A., et al. (2012) · Journal of Virology · doi:10.1128/jvi.07158-11 · Cited by 74
Universal influenza virus vaccines: need for clinical trials
Krammer, F., & Palese, P. (2013) · Nature Immunology · doi:10.1038/ni.2761 · Cited by 73
Self-citationShi, S., Yang, W., Yang, G., Cong, Y., Huang, H., Wang, Q., Cai, R., Ye, L.-P., Hu, J., Zhou, J., et al. (2014) · Virology · doi:10.1016/j.virol.2014.07.011 · Cited by 71
Protection against Lethal Influenza with a Viral Mimic
Baker, S. F., Guo, H., Albrecht, R. A., García‐Sastre, A., Topham, D. J., & Martínez‐Sobrido, L. (2013) · Journal of Virology · doi:10.1128/jvi.01081-13 · Cited by 69
Margine, I., Martínez‐Gil, L., Chou, Y., & Krammer, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051559 · Cited by 67
Self-citationDuBois, R. M., Aguilar‐Yáñez, J. M., Mendoza‐Ochoa, G. I., Oropeza‐Almazán, Y., Schultz‐Cherry, S., Álvarez, M. M., White, S. W., & Russell, C. J. (2010) · Journal of Virology · doi:10.1128/jvi.01412-10 · Cited by 66
Ducatez, M., Bahl, J., Griffin, Y., Stigger-Rosser, E., Franks, J., Barman, S., Vijaykrishna, D., Webb, A., Guan, Y., Webster, R. G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012457108 · Cited by 66
Stability of neuraminidase in inactivated influenza vaccines
Sultana, I., Yang, Y., Getie‐Kebtie, M., Couzens, L. K., Markoff, L. J., Alterman, M. A., & Eichelberger, M. C. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.078 · Cited by 66
An Influenza A/H1N1/2009 Hemagglutinin Vaccine Produced in Escherichia coli
Aguilar‐Yáñez, J. M., Lara, R. P., Mendoza‐Ochoa, G. I., Echauri, S. A. G., López‐Pacheco, F., Bulnes‐Abundis, D., Salgado-Gallegos, J., Lara-Mayorga, I. M., Webb-Vargas, Y., León-Angel, F. O., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011694 · Cited by 66
An, Y.-M., Rininger, J., Jarvis, D., Jing, X., Ye, Z., Aumiller, J. J., Eichelberger, M., & Cipollo, J. (2013) · Journal of Proteome Research · doi:10.1021/pr400329k · Cited by 66
Avian influenza A H10N8—a virus on the verge?
García‐Sastre, A., & Schmolke, M. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60163-x · Cited by 65
Wang, L., Hess, A., Chang, T. Z., Wang, Y., Champion, J. A., Compans, R. W., & Wang, B. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.08.005 · Cited by 65
Elicitation of Broadly Neutralizing Influenza Antibodies in Animals with Previous Influenza Exposure
Wei, C., Yassine, H. M., McTamney, P. M., Gall, J. G. D., Whittle, J. R. R., Boyington, J. C., & Nabel, G. J. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004273 · Cited by 64
Valkenburg, S. A., Li, O. T. W., Mak, P. W. Y., Mok, C. K. P., Nicholls, J. M., Guan, Y., Waldmann, T. A., Peiris, M. J. S., Perera, L. P., & Poon, L. L. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403684111 · Cited by 62
Sangster, M. Y., Baer, J., Santiago, F. W., Fitzgerald, T. F., Ilyushina, N. A., Sundararajan, A., Henn, A. D., Krammer, F., Yang, H., Luke, C. J., et al. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00735-12 · Cited by 60
Self-citationSaelens, X., Vanlandschoot, P., Martinet, W., Maras, M., Neirynck, S., Contreras, R., Fiers, W. C., & Jou, W. M. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00150.x · Cited by 59
Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans
Ledgerwood, J. E., Hu, Z., Gordon, I. J., Yamshchikov, G. V., Enama, M. E., Plummer, S. H., Bailer, R. T., Pearce, M. B., Tumpey, T. M., Koup, R. A., et al. (2012) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05663-11 · Cited by 58
Георгиевна, Р. Л., Kiseleva, I., Naykhin, A., Ерофеева, М. К., Stukova, M., Donina, S., Petukhova, G. D., Pisareva, M., Krivitskaya, V. Z., Grudinin, M. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087962 · Cited by 57
Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine With MF59 Adjuvant
Belshe, R. B., Frey, S. E., Graham, I. L., Anderson, E. L., Jackson, L. A., Spearman, P. W., Edupuganti, S., Mulligan, M. J., Rouphael, N., Winokur, P. L., et al. (2014) · JAMA · doi:10.1001/jama.2014.12609 · Cited by 55
Alternative influenza vaccines made by insect cells
Krammer, F., & Grabherr, R. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.05.002 · Cited by 55
Self-citationLin, S.-C., Lin, Y., Chong, P. C.-S., & Wu, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039075 · Cited by 53
Abed, Y., Hardy, I., Li, Y., & Boivin, G. (2002) · Journal of Medical Virology · doi:10.1002/jmv.10143 · Cited by 53
Bayne, A.-C. V., Boltz, D. A., Owen, C., Betz, Y., Maia, G., Azadi, P., Archer‐Hartmann, S. A., Zirkle, R., & Lippmeier, J. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061790 · Cited by 52
An H7N1 Influenza Virus Vaccine Induces Broadly Reactive Antibody Responses against H7N9 in Humans
Krammer, F., Jul‐Larsen, Å., Margine, I., Hirsh, A., Sjursen, H., Zambon, M. C. F. A., & Cox, R. J. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00272-14 · Cited by 52
Self-citationSALK, J. E., & Suriano, P. C. (1949) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.39.3.345 · Cited by 51
Lin, S.-C., Liu, W., Jan, J., & Wu, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092822 · Cited by 48
Doyle, T. M., Li, C., Bucher, D. J., Hashem, A. M., Domselaar, G. V., Wang, J., Farnsworth, A., She, Y., Cyr, T. D., He, R., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.041 · Cited by 46
Virus-Vectored Influenza Virus Vaccines
Tripp, R. A., & Tompkins, S. M. (2014) · Viruses · doi:10.3390/v6083055 · Cited by 46
Mullarkey, C. E., Boyd, A. C., van Laarhoven, A., Lefèvre, E. A., Carr, B. V., Baratelli, M., Molesti, E., Temperton, N. J., Butter, C., Charleston, B., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201242922 · Cited by 45
An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults
Talaat, K. R., Karron, R. A., Luke, C. J., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.043 · Cited by 42
Rapid Production of Synthetic Influenza Vaccines
Dormitzer, P. R. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_399 · Cited by 40
An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults
Talaat, K. R., Karron, R. A., Liang, P. H., McMahon, B. A., Luke, C. J., Thumar, B., Chen, G. L., Min, J., Lamirande, E. W., Jin, H., et al. (2012) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2012.00350.x · Cited by 40
Kreijtz, J. H. C. M., Suezer, Y., Bodewes, R., Schwantes, A., van Amerongen, G., Verburgh, R. J., de Mutsert, G., van den Brand, J. M. A., Trierum, S. E. V.-V., Kuiken, T., et al. (2010) · Journal of General Virology · doi:10.1099/vir.0.024885-0 · Cited by 40
Eliciting broadly protective antibody responses against influenza
Kirchenbaum, G. A., & Ross, T. M. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.02.005 · Cited by 39
Cell‐free production of trimeric influenza hemagglutinin head domain proteins as vaccine antigens
Welsh, J. P., Lu, Y., He, X.-S., Greenberg, H. B., & Swartz, J. R. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24581 · Cited by 38
Staneková, Z., Adkins, I., Kosová, M., JANULÍKOVÁ, J., Šebo, P., & Varečková, E. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.09.008 · Cited by 37
Krammer, F., Nakowitsch, S., Messner, P., Palmberger, D., Ferko, B., & Grabherr, R. M. (2009) · Biotechnology Journal · doi:10.1002/biot.200900267 · Cited by 37
Self-citationMatsuoka, Y., Suguitan, A. L., Orandle, M. S., Paskel, M., Boonnak, K., Gardner, D. J., Feldmann, F., Feldmann, H., Marino, M., Jin, H., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00425-14 · Cited by 32
Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms
Luke, C. J., & Subbarao, K. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.922416 · Cited by 29
Palmberger, D., Ashjaei, K., Strell, S., Hoffmann‐Sommergruber, K., & Grabherr, R. M. (2014) · Biotechnology Journal · doi:10.1002/biot.201300061 · Cited by 27
Krammer, F., & Cox, R. J. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.850036 · Cited by 23
Self-citationJANULÍKOVÁ, J., Staneková, Z., Mucha, V., Kostolanský, F., & Varečková, E. (2012) · Acta Virologica · doi:10.4149/av_2012_03_169 · Cited by 20
Prabakaran, M., Leyrer, S., He, F., Auer, S., Kumar, S. R., Kindsmüller, K., Mytle, N., Schneider, J., Lockhart, S. P., & Kwang, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107316 · Cited by 17
Biogenesis of Influenza A Virus Hemagglutinin Cross-Protective Stem Epitopes
Magadán, J. G., Altman, M. O., Ince, W. L., Hickman, H. D., Stevens, J., Chevalier, A. A., Baker, D. A., Wilson, P. C., Ahmed, R., Bennink, J. R., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004204 · Cited by 9
AS03-adjuvanted influenza vaccine in elderly people
Ledgerwood, J. E. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70038-0 · Cited by 7
Cited by
Krammer, F., Smith, G. J. D., Fouchier, R. A. M., Peiris, M., Kedzierska, K., Doherty, P. C., Palese, P., Shaw, M. L., Treanor, J., Webster, R. G., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0002-y · Cited by 1,570
Self-citationSARS-CoV-2 Vaccines: Status Report
Amanat, F., & Krammer, F. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.007 · Cited by 1,120
Self-citationThe evolution of seasonal influenza viruses
Petrova, V. N., & Russell, C. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.118 · Cited by 846
The human antibody response to influenza A virus infection and vaccination
Krammer, F. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0143-6 · Cited by 796
Self-citationmRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Maruggi, G., Zhang, C., Li, J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.020 · Cited by 507
Metadata
- Authors
- Krammer, F., & Palese, P.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-02-27
- Volume
- 14
- Issue
- 3
- Pages
- 167-182
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2095336525
- Cited by
- 597
- References
- 188
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.